POC Immunoassay Testing Market is Projected to Reach US $ XX Bn by 2025, Due to High Prevalence of Infectious Diseases in Developing Countries

08/feb/2019 10:26:31 sai krishna Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

POC Immunoassay Testing Market is Projected to Reach US $ XX Bn by 2025, Due to High Prevalence of Infectious Diseases in Developing Countries

 

The POC Immunoassay Testing Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to high prevalence of infectious diseases in developing countries.

 

Precision Business Insights (PBI) in its report titled “POC Immunoassay Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The POC immunoassay market size was accounted for US$ XX Bn in 2018 and anticipated to account for US$ XX Bn by 2025. Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, rising preference for home healthcare across the globe, and growing government initiatives supporting the adoption of POC diagnostic products are expected to drive the demand for point-of-care diagnostic products during the study period. However high cost associated with the testing procedure, withholds the growth of market.

 

Sample: https://precisionbusinessinsights.com/request-sample?product_id=23426

 

POC immunoassay market segmented on the basis of technology, product, platform, and end user.

 

Infectious Disease Testing Product Segments Expected to Dominate the Market

 

Based on product, the global Point-of-Care Diagnostics Market is segmented into glucose monitoring products, infectious disease testing products, coagulation testing products, cardiometabolic testing products, hematology testing products, urinalysis testing products, cholesterol testing products, drugs of abuse testing products, tumor/cancer marker testing products, pregnancy and fertility testing products, fecal occult testing products, and other POC products (multi-assay testing, liver testing, hepatitis A & B testing, and vitamin assay testing). The infectious disease testing products segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the growing patient population base and increasing availability and awareness about infectious disease POC testing products.

 

Home Care Segment Will Dominate the Revenue Share.

 

Based on end user, the Point-of-Care Diagnostics Market is segmented into professional diagnostic centers, home care, research laboratories, and other end users. The home care segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

 

North America, Accounts for Major Revenue Share for POC Immunoassay Testing Market

 

Precision Business Insights (PBI) POC immunoassay testing market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America is estimated to account for the largest share of the market in 2017. This can be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives to support the adoption of POC in this region. The Asia Pacific POC immunoassay testing market is expected to show the growth in the forecasted period owing to its increasing patient pool coupled with improving technology. It is expected that the market in Asia Pacific to display a robust growth rate during the assessed period attributed to an excellent performance of Japan.

 

Request Methodology:

 

https://precisionbusinessinsights.com/request-methodology?product_id=23426

 

 

Scintillating Market Strategy Play Vital Role in POC Immunoassay Testing Market

 

The increased R&D investment from pharmaceutical companies, research organizations and biotech companies are expected to create demand for POC immunoassay testing market. For instance, in November 2016, Abbott announced that i-STAT Alinity System, an innovative, handheld blood testing platform, received CE Mark and is now for sale in Europe and other countries that recognize CE Mark

Key player’s profiles in the report are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US) among others.

 

Detailed Segmentation

 

By Technology Type

 

o   ELISA

o   Others

 

By Product Type

 

o   Cardiometabolic monitoring kits

·         Electrolytes Testing Kits

·         Cardiac Markers Kits

·         HbA1c Testing Kits

·         Others

o   Infectious disease testing kits

·         HIV testing kits

·         Hepatitis testing kits

·         Respiratory infections testing kits

·         Sexually-transmitted diseases (STDs) testing kits

·         Influenza testing kits

·         Others

o   Pregnancy and fertility testing kits

·         Fertility Testing Kits

·         Pregnancy testing kits

o   Glucose monitoring kits

o   Hematology testing kits

o   Fecal Occult Testing Kits

o   Cholesterol Test Strips

o   Drugs of Abuse Testing Kits

o   Urinalysis Testing Kits

o   Others

 

By Platform Type

 

o   Molecular Diagnostics

o   Immunoassays

o   Lateral Flow Assays

o   Dipsticks

o   Microfluidics

 

By End-User Type

 

o   Hospitals/Diagnostic centers

o   Home Care

o   Research Laboratories

o   Others

 

Geography

 

o   North America

§  U.S.

§  Canada

o   Europe

§  Germany

§  UK

§  France

§  Russia

§  Spain

§  Italy

§  Rest of Europe

o   Asia-Pacific

§  China

§  Japan

§  India

§  ASEAN

§  Rest of Asia Pacific

o   Latin America

§  Brazil

§  Mexico

§  Argentina

§  Chile

§  Rest of Latin America

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  Rest of MEA

 

 

More Info:

https://precisionbusinessinsights.com/market-reports/poc-immunoassay-testing-market/

 

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl